96 related articles for article (PubMed ID: 9014525)
21. Prospective evaluation of the early effects of radiation on the auditory system frequencies of patients with head and neck cancers and brain tumors after radiotherapy.
Hajisafari A; Bakhshandeh M; Aghamiri SMR; Houshyari M; Rakhsha A; Bolokat ER; Rezazadeh A
Ear Nose Throat J; 2018 Mar; 97(3):E10-E17. PubMed ID: 29554405
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical study of c-fos-positive lymphocytes infiltrated into human squamous cell carcinomas of the head and neck during radiation therapy and its clinical significance.
Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2301-7. PubMed ID: 9815628
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
24. Current radiotherapic procedures and preservation of salivary function in patients with head and neck cancer.
Donato V; Bulzonetti N; Monaco A; Messineo D; Caiazzo R; Banelli E
Acta Otorhinolaryngol Ital; 2004 Oct; 24(5):275-8. PubMed ID: 15871608
[TBL] [Abstract][Full Text] [Related]
25. Intensity-modulated radiation therapy for head and neck cancer.
Chou WW; Puri DR; Lee NY
Expert Rev Anticancer Ther; 2005 Jun; 5(3):515-21. PubMed ID: 16001958
[TBL] [Abstract][Full Text] [Related]
26. Proton radiation therapy for head and neck cancer.
Chan AW; Liebsch NJ
J Surg Oncol; 2008 Jun; 97(8):697-700. PubMed ID: 18493920
[TBL] [Abstract][Full Text] [Related]
27. Intensity-modulated radiation therapy in the treatment of head and neck cancer.
Eisbruch A
Nat Clin Pract Oncol; 2005 Jan; 2(1):34-9. PubMed ID: 16264854
[TBL] [Abstract][Full Text] [Related]
28. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet- and speech-related quality of life.
Dornfeld K; Simmons JR; Karnell L; Karnell M; Funk G; Yao M; Wacha J; Zimmerman B; Buatti JM
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):750-7. PubMed ID: 17418971
[TBL] [Abstract][Full Text] [Related]
29. Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients.
Rades D; Fehlauer F; Bajrovic A; Mahlmann B; Richter E; Alberti W
Radiother Oncol; 2004 Mar; 70(3):261-4. PubMed ID: 15064010
[TBL] [Abstract][Full Text] [Related]
30. [Constraints to organs at risk for treatment of head and neck cancers by intensity modulated radiation therapy].
Maingon P; Mammar V; Peignaux K; Truc G; Barillot I
Cancer Radiother; 2004 Aug; 8(4):234-47. PubMed ID: 15450517
[TBL] [Abstract][Full Text] [Related]
31. Radiation therapy for head and neck cancers.
Mallick I; Waldron JN
Semin Oncol Nurs; 2009 Aug; 25(3):193-202. PubMed ID: 19635398
[TBL] [Abstract][Full Text] [Related]
32. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Rasch CR; Schornagel JH; Dreschler WA; Balm AJ
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1320-5. PubMed ID: 17418969
[TBL] [Abstract][Full Text] [Related]
33. Functional changes of the gustatory organ caused by local radiation exposure during radiotherapy of the head-and-neck region.
Kamprad F; Ranft D; Weber A; Hildebrandt G
Strahlenther Onkol; 2008 Mar; 184(3):157-62. PubMed ID: 18330512
[TBL] [Abstract][Full Text] [Related]
34. Intensity-modulated radiotherapy: first results with this new technology on neoplasms of the head and neck.
Kuppersmith RB; Greco SC; Teh BS; Donovan DT; Grant W; Chiu JK; Cain RB; Butler EB
Ear Nose Throat J; 1999 Apr; 78(4):238, 241-6, 248 passim. PubMed ID: 10224699
[TBL] [Abstract][Full Text] [Related]
35. Otolaryngologic sequelae of radiation therapy.
Kupperman GL; Kleiner H; Stageman DL; Martinelli D
Ear Nose Throat J; 1978 Nov; 57(11):510-5. PubMed ID: 710343
[No Abstract] [Full Text] [Related]
36. Etiological analysis of the sequelae of radiotherapy for nasopharyngeal carcinoma: a follow-up study of 112 cases.
Yan WP; Chen LH; Xu ZX; Deng XG
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1002-5. PubMed ID: 14559677
[TBL] [Abstract][Full Text] [Related]
37. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
[TBL] [Abstract][Full Text] [Related]
38. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.
Bairati I; Meyer F; Gélinas M; Fortin A; Nabid A; Brochet F; Mercier JP; Têtu B; Harel F; Mâsse B; Vigneault E; Vass S; del Vecchio P; Roy J
J Natl Cancer Inst; 2005 Apr; 97(7):481-8. PubMed ID: 15812073
[TBL] [Abstract][Full Text] [Related]
39. Decreased hearing after combined modality therapy for head and neck cancer.
Pearson SE; Meyer AC; Adams GL; Ondrey FG
Am J Otolaryngol; 2006; 27(2):76-80. PubMed ID: 16500467
[TBL] [Abstract][Full Text] [Related]
40. Quality-of-life measurement in patients undergoing radiation therapy for head and neck cancer: a Hong Kong experience.
Lo PS; Lo SK; Tong MC; Ku PK; Leung SF; van Hasselt CA
J Oncol Manag; 2004; 13(6):13-23. PubMed ID: 15648221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
